Nudge is one of the most high-profile consumer ultrasound BCI entrants, benefiting from Fred Ehrsam's profile and the narrative momentum of focused ultrasound as a next-generation non-invasive modality. Its consumer-first positioning distinguishes it from clinical ultrasound neuromodulation companies, though the regulatory and safety validation requirements for consumer ultrasound brain devices remain substantially unaddressed at this early stage.